[The effect of HBs-antigenemia on the clinical course of rheumatoid arthritis].
Our observations suggest that HBs-antigenemia may play a part in the heterogeneity of rheumatoid arthritis. This is manifested by some particular features of its clinical course, by disordered immunological reactivity, the functional state of the immunity B-system in particular. The greatest benefit from antirheumatic therapy occurred in those patients who received reaferon as part of their therapeutic programme.
M I
MI
Shved
N V
NV
Hrymaliuk
D000328:Adult; D000917:Antibody Formation; D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D002353:Carrier State / Q000175:diagnosis* / Q000276:immunology; D005260:Female; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D019694:Hepatitis B, Chronic / Q000175:diagnosis* / Q000276:immunology; D006801:Humans; D007159:Immunologic Tests; D008297:Male; D008875:Middle Aged; D013601:T-Lymphocytes / Q000276:immunology
D006514:Hepatitis B Surface Antigens